News

Deutsche Bank Initiates Coverage of Agilent Technologies at Buy

Fintel·21:49A▲+0.9%

Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow

Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.

ChartMill·07:50A▲+0.9%

$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 1.17% on an annualized basis producing an average annual return of 14.8%. Currently, Agilent Technologies has a market capitalization

Benzinga·06:45A▲+0.9%

Agilent acquires Proscia in deal worth up to $270m

The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.

Yahoo·07:11A▲+0.9%

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist

Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.

Benzinga·05:20A▲+0.9%

Agilent to buy Proscia for $240M

The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.

Yahoo·02:29A▲+0.9%

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.

Yahoo·08:00A▲+0.9%

TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196

TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.

Benzinga·07:39A▲+0.9%

Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Chromosomal Microarray Reflex Testing Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann

Yahoo·04:03A▲+0.9%

Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo·10:30

$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization

Benzinga·08:45A▲+0.9%

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.

Yahoo·08:00A▲+0.9%

Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story

Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...

Yahoo·02:12A▲+0.9%

Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo·10:30A▲+0.9%

If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Yahoo·08:30A▲+0.9%

Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation

Agilent Technologies (NYSE:A) executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company’s Ignite transformation program, during a J.P. Morgan conference discussion. Chief Executive Offi

Yahoo·07:02A▲+0.9%

Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript

Agilent Technologies, Inc. (A) U.S.

SeekingAlpha·06:09A▲+0.9%

Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A)

Let’s dig into the relative performance of Agilent (NYSE:A) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.

Yahoo·09:57A▲+0.9%

Capitalize on Label-Free Array Systems Disruption: Benchmark Agilent, Cytiva, Sartorius, Bio-Rad and PerkinElmer to Secure R&D ROI and Global Market Share

Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-free Array Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2

Yahoo·04:31A

Lithium Miners News For The Month Of September 2026

China lithium prices slide as key mine loses licence, while major producers’ profits and Argentina expansion plans reshape 2027 supply outlook. See more here.

SeekingAlpha·19:17

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

SANTA CLARA, Calif., September 21, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. The new CE-IVD-labeled systems and software are designed to support standardized and traceable quality control of DNA and RNA samples used in clinical next-generation sequenci

Yahoo·08:00A▲+0.9%

Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time

On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workflows. The launch is easy to overlook, but it arrives alongside a strong quarter, and that […]

Yahoo·15:52A▲+0.9%

CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share

SANTA CLARA, Calif., September 16, 2026--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly dividend will be paid on October 6, 2026, to all shareholders of record as of the close of business on October 28, 2026.).

Yahoo·18:59A▲+0.9%

1 Large-Cap Stock to Own for Decades and 2 We Turn Down

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

Yahoo·05:47

Global Mass Spectrometry Market to Reach USD 10.78 Billion by 2031, Driven by Biologics, Precision Medicine and LC-MS/MS Adoption

The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte

Yahoo·04:54

Superconducting Magnets - Global Strategic Business Report Now Available, Forecasts Market Growth from $3.9B (2024) to $4.7B by 2030, Profiling Agilent, Bruker, Fujikura, and 49 Other Key Players

Opportunities span advanced MRI, particle accelerators, fusion energy, mass spectrometry, quantum computing and transportation. Better superconducting materials and cooling can cut operating costs, while supply-chain shifts open new sourcing options.Dublin, Sept. 11, 2026 (GLOBE NEWSWIRE) -- "Superconducting Magnets - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Superconducting Magnets was valued at US$3.9 Billion in 2024 and is proj

Yahoo·09:09A▲+0.9%

Agilent to Participate in J.P. Morgan U.S. All Stars Conference

SANTA CLARA, Calif., September 10, 2026--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m. BST on Wednesday, Sept. 23, 2026, in London. A live audio webcast and replay of the presentation will be available through Agilent’s Investor Relations website.

Yahoo·16:15A▲+0.9%

Is Agilent Technologies Stock Outperforming the Dow?

Outpacing the Dow over the past 12 months, Agilent Technologies continues to receive a moderately bullish outlook from Wall Street analysts.

Yahoo·08:18A▲+0.9%

Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System

SANTA CLARA, Calif., September 04, 2026--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent’s ongoing commitment to digital pathology, broadening its portfolio to address the increasing demand for high-throughput solutions in clinical laboratories.

Yahoo·09:00A▲+0.9%

Agilent Technologies Rolls Out Agilent S540MD Slide Scanner System In U.S.

Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, following FDA clearance. This launch underscores Agilent’s

Benzinga·04:03A0.9%

Agilent: The Recovery Is Real, But So Is The Valuation

Agilent is rebounding in life science tools with strong recurring revenue and stabilizing margins, but DCF flags overvaluation. Read more on A stock here.

SeekingAlpha·01:47A▲+0.9%

Agilent Technologies: Files For Debt Shelf Offering; Size Not Disclosed

-SEC Filing

Benzinga·13:15A▲+0.9%

Agilent Introduces the Cary 635 FTIR Spectrometer

SANTA CLARA, Calif., September 01, 2026--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis. Combining robust engineering, superior performance, and intuitive usability, the Cary 635 FTIR provides laboratories with a powerful solution that enhances reliability, boosts productivity, and delivers the versatility required for today’s analytical chal

Yahoo·09:00A▲+0.9%

Agilent (A) Q3 2026 Earnings Call Transcript

Pharma revenue surged 12% while advanced therapeutics grew nearly 30%, beating guidance.

Yahoo·10:49A▲+0.9%

International Markets and Agilent (A): A Deep Dive for Investors

Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Yahoo·10:15A▲+0.9%

Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis

Agilent (NYSE) Expanded Non-GAAP Margin 320 bps. How Much Is Repeatable?

Agilent Technologies, Inc. (NYSE:A) delivered fiscal third-quarter revenue of $1.88 billion, an increase of 8.1% from a year earlier. Core revenue, which excludes currency movements and recent acquisitions and divestitures, grew 7.3%. The company-defined non-GAAP operating margin of Agilent Technologies, Inc. (NYSE:A) reached 28.3%, expanding 320 basis points year over year. Approximately 110 basis points […]

Yahoo·23:50A▲+0.9%

A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results

Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2026, with sales up 8.1% year on year to $1.88 billion. Guidance for next quarter’s revenue was better than expected at $1.99 billion at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $1.62 per share was 9% above analysts’ consensus estimates.

Yahoo·22:45A▲+0.9%

Agilent Technologies (A) Has Investors Looking Closer After Its Latest Update

Agilent Technologies (A) is back in focus after raising its fiscal 2026 revenue guidance to a range of $7.49b to $7.51b, alongside fresh fourth quarter projections tied to its latest earnings release. The raised 2026 guidance and stronger recent quarters have come alongside a clear shift in how the market is pricing Agilent Technologies, with a 30 day share price return of 12.20% and a 1 year total shareholder return of 27.21%, which points to building momentum rather than fading...

Yahoo·20:12

Lithium Miners News For The Month Of August 2026

Lithium prices rebound as CATL shutdown risks a deficit; miners post strong H1 results, and new supply deals form. Read the full news roundup here.

SeekingAlpha·07:46

Broadcom: Moving Big Into Vendor Financing

Broadcom Inc.: AI chip growth targets, SPV financing and default risks, insider selling, and valuation—see why investors may avoid now. Click for more on AVGO stock.

SeekingAlpha·13:24

Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.

Yahoo·10:15A▲+0.9%

What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?

Despite Agilent Technologies’ strong performance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Yahoo·13:14A▲+0.9%

MDT vs. A: Which Stock Should Value Investors Buy Now?

MDT vs. A: Which Stock Is the Better Value Option?

Yahoo·12:40

Cannabis Testing Services Market Research Report 2026-2031: Profiles Agilent, Eurofins, SGS, and 18 Other Companies

Dublin, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The "Cannabis Testing Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The global cannabis testing services market was valued at USD 359.68 million in 2025 and is expected to increase from USD 397.85 million in 2026 to USD 688.46 million by 2031. The market is projected to register a compound annual growth rate of 11.59% during the 2026-2031 forecast period.

Yahoo·11:40A▲+0.9%

Are Medical Stocks Lagging Adicet Bio (ACET) This Year?

Here is how Adicet Bio, Inc. (ACET) and Agilent Technologies (A) have performed compared to their sector so far this year.

Yahoo·10:40A▲+0.9%

Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside

SeekingAlpha·01:15

Danaher: 2027 Growth Reacceleration Should Drive Upside

SeekingAlpha·11:26

Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $175

Morgan Stanley analyst Kallum Titchmarsh maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $160 to $175.

Benzinga·07:37A▲+0.9%

Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test

Agilent Technologies (NYSE:A) secured expanded European approval for its PD-L1 IHC 22C3 pharmDx test for ovarian cancer applications. The CE-marked indication now covers patients with ovarian, fallopian tube, and primary peritoneal carcinoma in the EU. The move strengthens Agilent's oncology diagnostics portfolio and supports wider use of targeted cancer therapies in Europe. For readers looking to explore more stocks tied to the rise of data driven tools in cancer care and diagnostics, a...

Yahoo·19:17A▲+0.9%

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions (BLFS) delivered earnings and revenue surprises of +500.00% and +1.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo·17:40

Navigating Alphabet’s (GOOGL) AI Frontier

Bronte Capital, an investment management company, released its “Amalthea Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund posted a 6.49% net return in June, bringing the quarterly returns to 5.12%, compared to 3.17% and 14.48% for the globally diverse MSCI ACWI in ($A), respectively. The outperformance in June […]

Yahoo·10:35A▲+0.9%

Envista (NVST) Q2 Earnings and Revenues Surpass Estimates

Envista (NVST) delivered earnings and revenue surprises of +24.24% and +2.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo·18:10

Are Options Traders Betting on a Big Move in Agilent Technologies Stock?

Investors need to pay close attention to A stock based on the movements in the options market lately.

Yahoo·11:21A▲+0.9%

If You Invested $1000 in Keysight a Decade Ago, This is How Much It'd Be Worth Now

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Yahoo·08:30